blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3241822

EP3241822 - URAT1 INHIBITOR [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.02.2022
Database last updated on 22.05.2024
FormerThe patent has been granted
Status updated on  19.02.2021
FormerGrant of patent is intended
Status updated on  24.09.2020
FormerExamination is in progress
Status updated on  20.03.2020
FormerRequest for examination was made
Status updated on  06.10.2017
FormerThe international publication has been made
Status updated on  16.06.2017
Most recent event   Tooltip27.04.2024Lapse of the patent in a contracting state
New state(s): MK		published on 29.05.2024 [2024/22]
Applicant(s)For all designated states
Nippon Chemiphar Co., Ltd.
2-3, Iwamoto-cho 2-chome Chiyoda-ku
Tokyo 101-0032 / JP
For all designated states
J-Pharma Co., Ltd.
75-1 Onocho
Tsurumi-ku
Yokohama-shi
Kanagawa 230-0046 / JP
For all designated states
DeThree Res. Lab. Inc.
25-4 Saigo
Tsukuba-shi, Ibaraki 305-0036 / JP
[2021/12]
Former [2017/45]For all designated states
Nippon Chemiphar Co., Ltd.
2-3, Iwamoto-cho 2-chome Chiyoda-ku
Tokyo 101-0032 / JP
For all designated states
J-Pharma Co., Ltd.
75-1 Onocho
Tsurumi-ku
Yokohama-shi
Kanagawa 230-0046 / JP
For all designated states
Dethree Res. Lab. Inc.
25-4 Saigo
Tsukuba-shi, Ibaraki 305-0036 / JP
Inventor(s)01 / ENDO, Tsuyoshi
c/o Nippon Chemiphar Co. Ltd.
Discovery Research Laboratories
1-22 Hikokawado
Misato-shi Saitama 341-0005 / JP
02 / KOBAYASHI, Kunio
c/o Nippon Chemiphar Co. Ltd.
Discovery Research Laboratories
1-22 Hikokawado
Misato-shi Saitama 341-0005 / JP
03 / TANAKA, Hiroto
c/o Nippon Chemiphar Co. Ltd.
Discovery Research Laboratories
1-22 Hikokawado
Misato-shi Saitama 341-0005 / JP
04 / SAITO, Daisuke
c/o Nippon Chemiphar Co. Ltd.
Discovery Research Laboratories
1-22 Hikokawado
Misato-shi Saitama 341-0005 / JP
05 / HIRANO Masuharu
c/o Nippon Chemiphar Co. Ltd. Discovery Research
Laboratories
1-22
Hikokawado
Misato-shi Saitama 3410005 / JP
06 / ENDOU, Hitoshi
c/o J-Pharma Co. Ltd.
75-1 Onocho
Tsurumi-Ku
Yokohama-shi Kanagawa 230-0046 / JP
07 / ANZAI, Naohiko
Adeniumu Kichijoji 604
8-5-5 Shimorenjyaku
Mitaka-shi Tokyo 181-0013 / JP
 [2017/45]
Representative(s)Cabinet Becker et Associés
25, rue Louis le Grand
75002 Paris / FR
[2017/45]
Application number, filing date15875408.528.12.2015
[2017/45]
WO2015JP86482
Priority number, dateJP2014026700929.12.2014         Original published format: JP 2014267009
JP2015012839626.06.2015         Original published format: JP 2015128396
[2017/45]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016108282
Date:07.07.2016
Language:JA
[2016/27]
Type: A1 Application with search report 
No.:EP3241822
Date:08.11.2017
Language:EN
[2017/45]
Type: B1 Patent specification 
No.:EP3241822
Date:24.03.2021
Language:EN
[2021/12]
Search report(s)International search report - published on:JP07.07.2016
(Supplementary) European search report - dispatched on:EP19.07.2018
ClassificationIPC:C07C255/54, A61K31/277, A61K31/404, A61K31/423, A61K31/428, A61K31/433, A61K31/437, A61K31/4406, A61K31/47, A61P19/06, A61P43/00, C07C321/24, C07D209/08, C07D213/30, C07D215/20, C07D215/36, C07D263/54, C07D275/04, C07D277/62
[2017/45]
CPC:
C07D275/04 (EP,RU,US); C07C255/57 (KR); A61K31/277 (EP,KR,US);
A61K31/33 (EP,RU,US); A61K31/404 (EP,US); A61K31/423 (EP,RU,US);
A61K31/428 (EP,RU,US); A61K31/433 (EP,RU,US); A61K31/437 (EP,RU,US);
A61K31/4406 (EP,KR,US); A61K31/47 (EP,KR,US); A61P19/06 (EP);
A61P43/00 (EP); C07C255/54 (EP,RU,US); C07C321/24 (EP,RU,US);
C07D209/08 (EP,RU,US); C07D213/30 (EP,KR,RU,US); C07D215/20 (EP,KR,RU,US);
C07D215/36 (EP,US); C07D263/54 (EP,RU,US); C07D277/62 (EP,RU,US);
C07D285/14 (EP,RU,US); C07D411/04 (EP,RU,US); C07D417/12 (EP,RU,US);
C07D471/04 (EP,RU,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/45]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:URAT1-ANTIKÖRPER[2017/45]
English:URAT1 INHIBITOR[2017/45]
French:INHIBITEUR D'URAT1[2017/45]
Entry into regional phase15.06.2017Translation filed 
15.06.2017National basic fee paid 
15.06.2017Search fee paid 
15.06.2017Designation fee(s) paid 
15.06.2017Examination fee paid 
Examination procedure15.06.2017Examination requested  [2017/45]
15.06.2017Date on which the examining division has become responsible
07.02.2019Amendment by applicant (claims and/or description)
24.03.2020Despatch of a communication from the examining division (Time limit: M04)
21.07.2020Reply to a communication from the examining division
25.09.2020Communication of intention to grant the patent
21.01.2021Fee for grant paid
21.01.2021Fee for publishing/printing paid
21.01.2021Receipt of the translation of the claim(s)
Opposition(s)04.01.2022No opposition filed within time limit [2022/10]
Fees paidRenewal fee
18.12.2017Renewal fee patent year 03
10.12.2018Renewal fee patent year 04
10.12.2019Renewal fee patent year 05
10.12.2020Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU28.12.2015
AL24.03.2021
AT24.03.2021
CY24.03.2021
CZ24.03.2021
DK24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
MC24.03.2021
MK24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SI24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
IE28.12.2021
LU28.12.2021
[2024/22]
Former [2023/30]HU28.12.2015
AL24.03.2021
AT24.03.2021
CY24.03.2021
CZ24.03.2021
DK24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
MC24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SI24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
IE28.12.2021
LU28.12.2021
Former [2023/29]HU28.12.2015
AL24.03.2021
AT24.03.2021
CZ24.03.2021
DK24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
MC24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SI24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
IE28.12.2021
LU28.12.2021
Former [2022/48]AL24.03.2021
AT24.03.2021
CZ24.03.2021
DK24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
MC24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SI24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
IE28.12.2021
LU28.12.2021
Former [2022/46]AL24.03.2021
AT24.03.2021
CZ24.03.2021
DK24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
MC24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SI24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
LU28.12.2021
Former [2022/33]AL24.03.2021
AT24.03.2021
CZ24.03.2021
DK24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
MC24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SI24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
Former [2022/23]AL24.03.2021
AT24.03.2021
CZ24.03.2021
DK24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SI24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
Former [2022/13]AL24.03.2021
AT24.03.2021
CZ24.03.2021
DK24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SI24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
PT26.07.2021
IS24.12.2021
Former [2022/10]AL24.03.2021
AT24.03.2021
CZ24.03.2021
DK24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
PT26.07.2021
IS24.12.2021
Former [2022/08]AL24.03.2021
AT24.03.2021
CZ24.03.2021
DK24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
Former [2022/07]AL24.03.2021
AT24.03.2021
CZ24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
Former [2021/52]AT24.03.2021
CZ24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
Former [2021/51]AT24.03.2021
CZ24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
Former [2021/50]AT24.03.2021
CZ24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
PT26.07.2021
Former [2021/48]AT24.03.2021
CZ24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
RS24.03.2021
SE24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
Former [2021/46]AT24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
RS24.03.2021
SE24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
Former [2021/38]FI24.03.2021
HR24.03.2021
LV24.03.2021
RS24.03.2021
SE24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
Former [2021/37]FI24.03.2021
HR24.03.2021
LV24.03.2021
RS24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
Former [2021/36]FI24.03.2021
HR24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
Former [2021/35]FI24.03.2021
HR24.03.2021
NO24.06.2021
Former [2021/33]FI24.03.2021
NO24.06.2021
Documents cited:Search[A]EP1698348  (HUMAN CELL SYSTEMS INC [JP]) [A] 1-15* claims 5-11 *;
 [A]WO2010135530  (ARDEA BIOSCIENCES INC [US], et al) [A] 1-15 * abstract * * claim 1 *;
 [A]WO2011159840  (ARDEA BIOSCIENCES INC [US], et al) [A] 1-15 * abstract * * claim 1 *;
 [A]WO2011159839  (ARDEA BIOSCIENCES INC [US], et al) [A] 1-15 * abstract * * claim 1 *
International search[A]US2005080105  (BOY KENNETH M [US], et al) [A] 1-61 * , example 1 (Family: none) *;
 [A]JP2008531473  (University of Wollongong) [A] 1-61* , paragraph [0134] & US 2008/0300287 A1 paragraph [0235] & WO 2006/074501 A1 & EP 1836159 A & NO 20074167 A & CA 2594411 A & KR 10-2007-0110849 A & CN 101142175 A & AU 2005325054 A & MX 2007008585 A *;
 [A]  - JEPSEN, TUE HEESGAARD et al., "Synthesis of Functionalized Dibenzothiophenes - An Efficient Three-Step Approach Based on Pd-Catalyzed C-C and C-S Bond Formations", European Journal of Organic Chemistry, (20110000), vol. 2011, no. 1, pages 53 - 57, XP055450916 [A] 1-61 * , compound 4j, DOI:10.1002/ejoc.201001393 *

DOI:   http://dx.doi.org/10.1002/ejoc.201001393
 [A]  - M. F. EL-NEWAIHY et al., "Condensation of Aryl Benryl Ketones with Dimethyl Diglycollate", Journal Fuer Praktissche Chemie (Leipzing), (19800000), vol. 322, pages 42 - 48, XP055450924 [A] 1-61 * , compound 5 *
 [A]  - BREMNER, JOHN B. et al., "Synthesis and antibacterial studies of binaphthyl-based tripeptoids. Part 2", Bioorganic & Medicinal Chemistry, (20100000), vol. 18, no. 13, pages 4793 - 4800, XP027083667 [A] 1-61 * , Scheme 1, Scheme 2, DOI:10.1016/j.bmc.2010. 05.005 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.